NRX PharmaceuticalsNRXP
13F holders, Q2 2025 (June 30)25holders +3
5new positions
2sold out
1famous investor
$3.26avg. 13F price*
At the end of Q2 2025, 25 institutions reported holding NRX Pharmaceuticals Inc. (NRXP) in their 13F filings, up 3 from Q1 2025. 5 opened new positions and 2 sold out. The largest holders were Anson Funds Management LP ($5.2M), Vanguard Group Inc. ($1.5M) and AdvisorShares Investments LLC ($860K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- NRX Pharmaceuticals Inc.
- CUSIP
- 629444209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $461K |
| Exits | 2 | $31K |
All 13F filers, Q1 2025 → Q2 2025: 835,284 shares bought and 101,440 shares sold, net +733,844 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 25 holders
| Anson Funds Management LP | 0.97% | Add +36.1% | 1,604,975 | $5.2M |
| Vanguard Group Inc. | 0.00% | Add +16.3% | 452,175 | $1.5M |
| AdvisorShares Investments LLC | 0.15% | Reduce -8.0% | 263,797 | $860K |
| Geode Capital Management, LLC | 0.00% | Add +27.9% | 172,255 | $562K |
| UBS Group AG | 0.00% | Add +115717.1% | 121,608 | $396K |
| Citadel Advisors | 0.00% | New | 92,361 | $301K |
| BlackRock, Inc. | 0.00% | Add +121.5% | 64,400 | $210K |
| State Street Corp. | 0.00% | Add +16.8% | 51,084 | $167K |
| Squarepoint Ops LLC | 0.00% | New | 42,202 | $138K |
| Marshall Wace, LLP | 0.00% | Reduce -62.5% | 33,384 | $109K |
| Two Sigma Investments, LP | 0.00% | Add +4.3% | 31,452 | $103K |
| Northern Trust Corp. | 0.00% | No change | 28,601 | $93K |
| One Wealth Management Investment & Advisory Services, LLC | 0.06% | No change | 15,041 | $49K |
| Morgan Stanley | 0.00% | Reduce -63.0% | 4,396 | $14K |
| Bank of America Corp. | 0.00% | Add +5.4% | 3,524 | $11K |
| SBI Securities Co., Ltd. | 0.00% | Add +69.6% | 3,392 | $11K |
| Group One Trading LLC | 0.00% | New | 3,108 | $10K |
| Raymond James Financial Inc. | 0.00% | New | 2,571 | $8K |
| Wells Fargo & Company | 0.00% | Reduce -7.4% | 2,000 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,156 | $4K |
| Simplex Trading, LLC | 0.00% | Add +9.0% | 690 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 90 | $293 |
| Carolina Wealth Advisors, LLC | 0.00% | No change | 50 | $163 |
| JPMorgan Chase & Co. | 0.00% | No change | 34 | $111 |
| Larson Financial Group LLC | 0.00% | No change | 22 | $72 |
"% of holder's portfolio" is NRXP's weight in each manager's 13F, not the share of NRX Pharmaceuticals Inc. the manager owns.